Private equity investment in healthcare — spanning physician practice management, home health, behavioral health, dental, dermatology, and healthcare IT — has totaled over $1 trillion over the past decade and fundamentally reshaped significant segments of healthcare delivery. The Walgreens Boots Alliance take-private by Sycamore Partners is the largest healthcare PE transaction in years. Private equity's influence on healthcare quality, pricing, and access has attracted unprecedented regulatory and legislative scrutiny — FTC enforcement actions, state attorney general investigations, and Congressional hearings have created a more challenging regulatory environment for healthcare PE transactions.
Topics Covered
• Healthcare PE Investment Trends
• PE in Physician Practices
• Home Health and Behavioral Health PE
• Healthcare IT PE Activity
• Walgreens Take-Private Analysis
• Regulatory Scrutiny of Healthcare PE
• PE Exit Strategy in Healthcare
• Outlook 2026-2030
Table of Contents
1. Executive Summary
2. Market and Policy Overview
3. Healthcare PE Investment Trends
4. PE in Physician Practices
5. Home Health and Behavioral Health PE
6. Healthcare IT PE Activity
7. Walgreens Take-Private Analysis
8. Regulatory Scrutiny of Healthcare PE
9. PE Exit Strategy in Healthcare
10. Outlook 2026-2030
11. Strategic Conclusions and Recommendations
12. Appendix
List of Tables
Table 1. Policy and Market Overview 2025
Table 2. Healthcare PE Investment Trends
Table 3. PE in Physician Practices
Table 4. Home Health and Behavioral Health PE
Table 5. Healthcare IT PE Activity
Table 6. Walgreens Take-Private Analysis
Table 7. Regulatory Scrutiny of Healthcare PE
Table 8. PE Exit Strategy in Healthcare
Table 9. Outlook 2026-2030
Table 10. Leading Companies — Strategy and Response 2025
Table 11. Regulatory Timeline and Key Dates
Table 12. Key Risks and Mitigation Strategies
Companies Profiled
Apollo
Blackstone
Carlyle
Francisco Partners
GTCR
KKR
Sycamore Partners
Warburg Pincus
Welsh Carson
